Sabrina da Silva
Universidade do Extremo Sul Catarinense
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Sabrina da Silva.
Free Radical Research | 2009
Marisa J. S. Frederico; Simoni L. Justo; Gabrielle da Luz; Sabrina da Silva; Cleber Medeiros; Viviane A. Barbosa; Luciano A. Silva; Carina R. Boeck; Ricardo A. Pinho; Cláudio T. De Souza
Exercise training has demonstrated cardioprotection effects. However, the exact mechanism behind this effect is not is clear. The present study evaluated the effects of 12 weeks of previous treadmill training on the levels of oxidative damage, antioxidant enzyme activity and injury in the myocardium of rats submitted to infarction induced by isoproterenol (ISO). Isoproterenol treatment (80 mg/kg given over 2 days in two equal doses) caused arrhythmias and 60% mortality within 24 h of the last injection in the control group (C + ISO) group when compared with the saline control group (saline). Creatine Kinase − MB levels were markedly increased in hearts from ISO-treated animals in the C + ISO group. Twelve weeks of treadmill training reduced superoxide production, lipid peroxidation levels and protein carbonylation in these animals, as well as increasing the activities and expressions of SOD and CAT. Previous training also reduced CK-MB levels and numbers of deaths by 40%, preventing the deleterious effects of ISO. Based on the data obtained in this study, it is suggested that 12-week treadmill training increases antioxidant enzymes, decreases oxidative damage and reduces the degree of infarction induced by ISO in the hearts of male rats.
Behavioural Brain Research | 2016
Josiane Budni; Robson Pacheco; Sabrina da Silva; Michelle Lima Garcez; Francielle Mina; Tatiani Bellettini-Santos; Jesiel de Medeiros; Bruna Constantino Voss; Amanda V. Steckert; Samira S. Valvassori; João Quevedo
d-Galactose (d-gal) is a reducing sugar that can be used to mimic the characteristics of aging in rodents; however, the effects of d-gal administration by oral route are not clear. Therefore, the aim of this study was to elucidate if the oral administration of d-gal induces cognitive impairments, neuronal loss, and oxidative damage, mimicking an animal model of aging. Male adult Wistar rats (4 months old) received d-gal (100mg/kg) via the oral route for a period of 1, 2, 4, 6 or 8 weeks. The results showed cognitive impairments in the open-field test in the 4th and 6th weeks after d-gal administration, as well as an impairment in spatial memory in the radial maze test after the 6th week of d-gal administration. The results indicated increase of levels of thiobarbituric acid reactive species-TBARS-and carbonyl group content in the prefrontal cortex from the 4th week, and in all weeks of d-gal administration, respectively. An increase in the levels of TBARS and carbonyl group content was observed in the hippocampus over the entire period of d-gal treatment. In the 8th week of d-gal administration, we also observed reductions in synaptophysin and TAU protein levels in the prefrontal cortex. Thus, d-gal given by oral route caused cognitive impairments which were accompanied by oxidative damage. Therefore, these results indicate that orally administered d-gal can induce the behavioral and neurochemical alterations that are observed in the natural aging process. However, oral d-gal effect in rats deserve further studies to be better described.
Molecular Medicine | 2012
Fabricia Petronilho; Francieli Vuolo; Leticia S. Galant; Larissa Constantino; Cristiane Damiani Tomasi; Vinícius Giombelli; Cláudio T. De Souza; Sabrina da Silva; Denise Frediani Barbeiro; Francisco Garcia Soriano; Emilio L. Streck; Cristiane Ritter; Alfeu Zanotto-Filho; Matheus Augusto de Bittencourt Pasquali; Daniel Pens Gelain; José Luiz Rybarczyk-Filho; José Cláudio Fonseca Moreira; Norman L. Block; Rafael Roesler; Gilberto Schwartsmann; Andrew V. Schally; Felipe Dal-Pizzol
In sepsis, toll-like receptor (TLR)-4 modulates the migration of neutrophils to infectious foci, favoring bacteremia and mortality. In experimental sepsis, organ dysfunction and cytokines released by activated macrophages can be reduced by gastrin-releasing peptide (GRP) receptor (GRPR) antagonist RC-3095. Here we report a link between GRPR and TLR-4 in experimental models and in sepsis patients. RAW 264.7 culture cells were exposed to lipopolysaccharide (LPS) or tumor necrosis factor (TNF)-α and RC-3095 (10 ng/mL). Male Wistar rats were subjected to cecal ligation and puncture (CLP), and RC-3095 was administered (3 mg/kg, subcutaneously); after 6 h, we removed the blood, bronchoalveolar lavage, peritoneal lavage and lung. Human patients with a clinical diagnosis of sepsis received a continuous infusion with RC-3095 (3 mg/kg, intravenous) over a period of 12 h, and plasma was collected before and after RC-3095 administration and, in a different set of patients with systemic inflammatory response syndrome (SIRS) or sepsis, GRP plasma levels were determined. RC-3095 inhibited TLR-4, extracellular-signal-related kinase (ERK)-1/2, Jun NH2-terminal kinase (JNK) and Akt and decreased activation of activator protein 1 (AP-1), nuclear factor (NF)-κB and interleukin (IL)-6 in macrophages stimulated by LPS. It also decreased IL-6 release from macrophages stimulated by TNF-α. RC-3095 treatment in CLP rats decreased lung TLR-4, reduced the migration of cells to the lung and reduced systemic cytokines and bacterial dissemination. Patients with sepsis and systemic inflammatory response syndrome have elevated plasma levels of GRP, which associates with clinical outcome in the sepsis patients. These findings highlight the role of GRPR signaling in sepsis outcome and the beneficial action of GRPR antagonists in controlling the inflammatory response in sepsis through a mechanism involving at least inhibition of TLR-4 signaling.
Materials Science and Engineering: C | 2017
Alexandre Pastoris Muller; Gabriela Kozuchovski Ferreira; Sabrina da Silva; Renata Tiscoski Nesi; Gustavo de Bem Silveira; Carolini Mendes; Ricardo A. Pinho; Marcos Marques da Silva Paula; Paulo Cesar Lock Silveira
Gold nanoparticles (GNPs) have antioxidant and anti-inflammatory effects. However, toxicity is still a concern; therefore, it is critical to study both the therapeutic and toxic properties of GNPs. In this study, we evaluated the effects of the intraperitoneal administration of GNPs (20nm, at a concentration of 2.5mg/L for 21days) every 24 or 48h on oxidative stress, antioxidant status, and electron chain transport (ETC) in the brain. Liver histology and blood marker analyses were conducted to establish a time routine of GNP administration. The concentrations of GNP in the brain and liver were similar. Hepatic and serum levels of cholesterol, triglycerides, and transaminases were not altered after the administration of GNP every 24 or 48h. The superoxide and nitric oxide levels were unchanged after administration of GNP. Dichlorodihydrofluorescein (DCFH) levels decreased after the administration of GNP every 48h compared with that in the saline group. Sulfhydryl and carbonyl levels, as well as superoxide dismutase (SOD), glutathione peroxidase (GPx), catalase (CAT), and glutathione (GSH) activities were not altered in the brain after administration of GNP in the two time periods studied. The GNP 48h group showed increased brain ETC activity. Compared to that in the saline group, the GNP 24h group showed marked parenchyma changes with cell necrosis and leukocyte infiltration. We therefore suggest that a concentration of 2.5mg/L of GNP administered every 48h has potential therapeutic benefits without toxicity.
Revista De Nutricao-brazilian Journal of Nutrition | 2012
Gabrielle da Luz; Sabrina da Silva; Scherolin O. Marques; Thais F. Luciano; Cláudio T. De Souza
OBJECTIVE: The aim of the present study was to assess the effects of omega-3 polyunsaturated fatty acid supplementation on insulin signaling and the proinflammatory pathway in the liver tissue of mice. METHODS: Swiss mice were divided into six groups given different dosages of fish oil containing omega-3 (1mg, 5mg, 10mg and 50mg) by gavage. The control group was given water. Fasting plasma glucose was measured on days 0 (no supplementation), 14 and 21 (after supplementation) to determine the dosage and timedependent effects of omega-3. Because the group n-3-21days (21 days of omega-3 supplementation) demonstrated lower blood glucose, this time interval was selected for molecular analysis. After an 8hour fast, liver tissue samples were taken from the control and n-3-21days groups, and western blot analyses were performed to assess insulin signaling and the proinflammatory pathway. RESULTS: The results showed that the dosage of 10mg leads to greater reduction in blood glucose at 14 and 21 days when compared with other dosages. Thus, this dosage was selected for molecular analysis. This dosage significantly decreased phosphorylation of cJun nterminal protein kinase and IkB kinase and protein levels of nuclear factor Kappalightchainenhancer of activated B cells. In parallel, increased insulin pathway signaling was observed, as confirmed by increases in insulin receptors, insulin receptor substrate 1 and protein kinase B phosphorylation. CONCLUSION: The present study suggests that omega-3 fatty acids improve insulin signaling by reducing inflammation. These results may be one of the explanations for low fasting glucose.
Journal of Cellular Biochemistry | 2017
Afonso Kopczynski de Carvalho; Sabrina da Silva; Edenir Serafini; Daniela R. Souza; Hemelin Resende Farias; Gustavo de Bem Silveira; Paulo Cesar Lock Silveira; Cláudio T. De Souza; Luis Valmor Cruz Portela; Alexandre Pastoris Muller
Diabetes mellitus is a metabolic disorder characterized by hyperglycemia. We investigated the effect of a prior 30 days voluntary exercise protocol on STZ‐diabetic CF1 mice. Glycemia, and the liver and skeletal muscle glycogen, mitochondrial function, and redox status were analyzed up to 5 days after STZ injection. Animals were engaged in the following groups: Sedentary vehicle (Sed Veh), Sedentary STZ (Sed STZ), Exercise Vehicle (Ex Veh), and Exercise STZ (Ex STZ). Exercise prevented fasting hyperglycemia in the Ex STZ group. In the liver, there was decreased on glycogen level in Sed STZ group but not in EX STZ group. STZ groups showed decreased mitochondrial oxygen consumption compared to vehicle groups, whereas mitochondrial H2O2 production was not different between groups. Addition of ADP to the medium did not decrease H2O2 production in Sed STZ mice. Exercise increased GSH level. Sed STZ group increased nitrite levels compared to other groups. In quadriceps muscle, glycogen level was similar between groups. The Sed STZ group displayed decreased O2 consumption, and exercise prevented this reduction. The H2O2 production was higher in Ex STZ when compared to other groups. Also, GSH level decreased whereas nitrite levels increased in the Sed STZ compared to other groups. The PGC1 α levels increased in Sed STZ, Ex Veh, and Ex STZ groups. In summary, prior exercise training prevents hyperglycemia in STZ‐mice diabetic associated with increased liver glycogen storage, and oxygen consumption by the mitochondria of skeletal muscle implying in increased oxidative/biogenesis capacity, and improved redox status of both tissues. J. Cell. Biochem. 118: 678–685, 2017.
Experimental Gerontology | 2018
Michelle Lima Garcez; Carlos Alberto de Carvalho; Francielle Mina; Tatiani Bellettini-Santos; Gustavo Luis Schiavo; Sabrina da Silva; Ana Carolina Brunatto Falchetti Campos; Roger B. Varela; Samira S. Valvassori; Adriani Paganini Damiani; Luiza Martins Longaretti; Vanessa Moraes de Andrade; Josiane Budni
&NA; Aging is a complex biological process. Epigenetic alterations have been related to both aging and memory decline. Included amongst these alterations is histone acetylation, which may play a crucial role in aging. Thus, the aims of the present study were to standardize the animal model of D‐galactose (D‐gal), and to evaluate the effects caused by sodium butyrate (SB), which is a histone deacetylase inhibitor on memory, the modulation of histone deacetylases (HDACs), and also DNA damage in 2, 6 or 16‐month‐old Wistar rats which were subjected to administrations of D‐gal. To help choose the best dose of D‐gal for the induction of the aging model, we performed a dose‐response curve (100, 200 or 300 mg/kg). D‐Gal was administered orally to the 2‐month‐old rats for a period of 30 days. After this, D‐gal (200 mg/kg) or water were administered to the 2, 6 or 16‐month‐old rats for a period of 30 days. On the 24th day, treatment was started with SB (600 mg/kg) intraperitoneally, for a period of 7 days. SB was able to reverse the damage to habituation memory caused by D‐gal in the 2 and 6‐month‐old rats, but was unable to reverse the damage in the 16 month‐old animals. In addition, SB was able to reverse the damage caused by natural aging in the 16‐month‐old animals. In the inhibitory avoidance task, SB improved the damage caused by D‐gal in the 2, 6 and 16‐month‐old animals and had the same result against the effects of natural aging in the 16‐month‐old rats. Moreover, D‐gal caused an increase in the level of HDACs activity in the 16‐month‐old animals, and SB was able to reverse this effect in the frontal cortex and hippocampus. The 16‐month‐old animals showed an increase in the frequency of DNA damage in peripheral blood, and SB was able to reduce this damage. Moreover, D‐gal caused an increase in the index and frequency of DNA damage in the 2 and 6‐month‐old animals, and treatment with SB was able to prevent this damage. Thus, the present study showed the protective effects of SB on the memory of naturally aged and D‐gal induced aging in rats. Therefore, the present study shows new findings for the use of SB in aging.
European Journal of Applied Physiology | 2011
Gabrielle da Luz; Marisa J. S. Frederico; Sabrina da Silva; Marcelo F. Vitto; Patrícia A. Cesconetto; Ricardo A. Pinho; José Rodrigo Pauli; Adelino Sanchez Ramos da Silva; Dennys E. Cintra; Eduardo R. Ropelle; Cláudio T. De Souza
Molecular Neurobiology | 2017
Thais Ceresér Vilela; Alexandre Pastoris Muller; Adriani Paganini Damiani; Tamires P. Macan; Sabrina da Silva; Paula Bortoluzzi Canteiro; Alisson de Sena Casagrande; Giulia S. Pedroso; Renata Tiscoski Nesi; Vanessa Moraes de Andrade; Ricardo A. Pinho
Metabolic Brain Disease | 2017
Josiane Budni; Michelle Lima Garcez; Francielle Mina; Tatiani Bellettini-Santos; Sabrina da Silva; Aline Pereira da Luz; Gustavo Luiz Schiavo; Hemily Batista-Silva; Giselli Scaini; Emilio L. Streck; João Quevedo